Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing …
Over the last 12 months, insiders at Sonnet BioTherapeutics Holdings, Inc. have bought $80,000 and sold $0 worth of Sonnet BioTherapeutics Holdings, Inc. stock.
On average, over the past 5 years, insiders at Sonnet BioTherapeutics Holdings, Inc. have bought $84,388 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Mohan Pankaj (Chairman, President and CEO) — $110,000. Rao Raghu (director) — $25,000.
The last purchase of 34,375 shares for transaction amount of $55,000 was made by Mohan Pankaj (Chairman, President and CEO) on 2023‑10‑27.
2023-10-27 | Chairman, President and CEO | 34,375 2.7322% | $1.60 | $55,000 | +27.83% | |||
2023-10-27 | director | 15,625 1.2419% | $1.60 | $25,000 | +27.83% | |||
2023-06-14 | Chief Technical Officer | 10,000 0.0581% | $0.70 | $7,000 | -88.47% | |||
2023-05-30 | director | 23,255 0.1328% | $0.47 | $10,883 | -82.67% | |||
2023-05-17 | director | 25,000 0.1518% | $0.23 | $5,800 | -61.35% | |||
2023-05-15 | Chairman, President and CEO | 371,600 2.2431% | $0.22 | $82,867 | -59.81% | |||
2023-03-15 | Chairman, President and CEO | 60,000 0.3794% | $0.58 | $35,100 | -70.60% | |||
2021-06-09 | Chairman, President and CEO | 32,000 0.144% | $1.55 | $49,580 | -65.16% | |||
2021-06-09 | Chief Medical Officer | 15,000 0.0671% | $1.54 | $23,100 | -65.16% | |||
2021-05-19 | Chief Medical Officer | 10,000 0.0444% | $1.55 | $15,500 | -62.10% | |||
2020-06-11 | director | 2,409 0.0221% | $4.01 | $9,660 | -34.28% | |||
2020-06-10 | Chairman, President and CEO | 2,400 0.0216% | $4.09 | $9,816 | -36.76% | |||
2020-03-23 | CEO, Chairman | 7,000 0.0699% | $0.58 | $4,078 | -78.31% | |||
2020-03-23 | President | 5,000 0.0433% | $0.51 | $2,528 | -78.31% | |||
2020-01-31 | CEO, Chairman | 206 – | $0 | $0 | -82.68% | |||
2019-12-10 | CEO, Chairman | 200 0.0004% | $0.62 | $124 | -77.56% | |||
2019-11-19 | CEO, Chairman | 2,000 0.0039% | $0.70 | $1,410 | -80.36% | |||
2019-11-17 | CEO, Chairman | 165 0.0003% | $0.64 | $106 | -76.27% | |||
2019-08-23 | CEO, Chairman | 1,000 0.0008% | $0.57 | $572 | -65.73% | |||
2019-08-19 | CEO, Chairman | 5,000 0.0036% | $0.61 | $3,050 | -70.41% |
Mohan Pankaj | Chairman, President and CEO | 59526 1.1442% | $0.73 | 5 | 0 | <0.0001% |
Rao Raghu | director | 16813 0.3232% | $0.73 | 1 | 0 | |
SPITCAUFSKY LARRY | 89689 1.724% | $0.73 | 7 | 8 | ||
Kenney Richard T | Chief Medical Officer | 50000 0.9611% | $0.73 | 2 | 0 | |
Pruitt Michael D | CEO, Chairman | 35462 0.6816% | $0.73 | 74 | 0 |